Marina Vivarelli
Overview
Explore the profile of Marina Vivarelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
2974
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vivarelli M, Samuel S, Coppo R, Nakanishi K
Pediatr Nephrol
. 2025 Feb;
PMID: 39982458
No abstract available.
2.
Hengel F, Dehde S, Yilmaz A, Bayazit A, Ozaltin F, Paripovic D, et al.
Kidney Int
. 2025 Feb;
PMID: 39922375
Objective: Autoantibodies against the podocyte protein nephrin were recently identified in a pediatric cohort primarily comprising steroid-sensitive (SSNS) and steroid-dependent (SDNS) nephrotic syndrome (NS). However, their prevalence across all NS...
3.
Zurowska A, Drozynska-Duklas M, Topaloglu R, Bouts A, Boyer O, Shenoy M, et al.
Pediatr Nephrol
. 2024 Dec;
40(3):877-878.
PMID: 39699592
No abstract available.
4.
Cappoli A, Kersnik-Levart T, Silecchia V, Ariceta G, Gjerstad A, Ghiggeri G, et al.
Pediatr Nephrol
. 2024 Nov;
40(4):979-986.
PMID: 39589481
Background: C3 glomerulopathy is a rare clinical entity characterized by dysregulation of the alternative complement pathway in glomerular disease. Studies defining the natural history of C3G in the pediatric population...
5.
Chan E, Sinha A, Yu E, Akhtar N, Angeletti A, Bagga A, et al.
Kidney Int
. 2024 Oct;
106(6):1146-1157.
PMID: 39395629
The efficacy and safety of rituximab in childhood steroid-resistant nephrotic syndrome (SRNS) remains unclear. Therefore, we conducted a retrospective cohort study at 28 pediatric nephrology centers from 19 countries in...
6.
Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum
Kavanagh D, Ardissino G, Brocklebank V, Bouwmeester R, Bagga A, Ter Heine R, et al.
Kidney Int
. 2024 Oct;
106(6):1038-1050.
PMID: 39395628
Hemolytic uremic syndromes (HUSs) are a heterogeneous group of conditions, only some of which are mediated by complement (complement-mediated HUS). We report the outcome of the 2023 International Society of...
7.
Hari P, Khandelwal P, Boyer O, Bhimma R, Cano F, Christian M, et al.
Pediatr Nephrol
. 2024 Oct;
40(3):865-872.
PMID: 39384644
Assessment of the true impact of therapeutic interventions is a challenge in the absence of universal, standardized definitions for clinical trial endpoints in children with kidney diseases. Steroid-resistant nephrotic syndrome...
8.
Vivarelli M, Samuel S, Coppo R, Barratt J, Bonilla-Felix M, Haffner D, et al.
Pediatr Nephrol
. 2024 Sep;
40(2):533-569.
PMID: 39331079
IgA nephropathy and IgA vasculitis with nephritis, albeit rare, represent two relatively frequent glomerular conditions in childhood. Compared to adults, pediatric IgA nephropathy has a more acute presentation, most frequently...
9.
Nester C, Feldman D, Burwick R, Cataland S, Chaturvedi S, Cook H, et al.
Kidney Int
. 2024 Aug;
106(3):326-336.
PMID: 39174192
The term atypical hemolytic uremic syndrome has been in use since the mid-1970s. It was initially used to describe the familial or sporadic form of hemolytic uremic syndrome as opposed...
10.
Vivarelli M, Barratt J, Beck Jr L, Fakhouri F, Gale D, Goicoechea de Jorge E, et al.
Kidney Int
. 2024 Jun;
106(3):369-391.
PMID: 38844295
Uncontrolled complement activation can cause or contribute to glomerular injury in multiple kidney diseases. Although complement activation plays a causal role in atypical hemolytic uremic syndrome and C3 glomerulopathy, over...